In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners.[5] The company went public on April 4, 2014 and began trading on the NYSE under the symbol IMS.[1][6] Ari Bousbib is IMS Health’s Chairman and CEO.